Michelle S Bradbury

USPTO Granted Patents = 21 (Patent Applications = 14)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 103(Granted Patents)

Company Filing History:

Memorial Sloan Kettering Cancer Center

patents

6 out of 512

Sloan-kettering Institute for Cancer Research

patents

4. 2 out of 2

Quest Medical Imaging B.v

patents

5. 2 out of 872

University of Missouri

patents

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268742 - Nanotherapeutic systems and methods using particle-driven photodynamic therapy (PDT) (2025-04-08),

2. 12161734 - Multimodal silica-based nanoparticles (2024-12-10),

3. 12082907 - Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real-time (2024-09-10),

4. 11931425 - Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis (2024-03-19),

5. 11666411 - Systems for augmented reality surgical and clinical visualization (2023-06-06),

6. 11660354 - Inhibitor-functionalized ultrasmall nanoparticles and methods thereof (2023-05-30),

7. 11559591 - Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof (2023-01-24),

8. 11419955 - Multimodal silica-based nanoparticles (2022-08-23),

9. 11246946 - Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis (2022-02-15),

10. 10986997 - Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time (2021-04-27),

11. 10940216 - Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging (2021-03-09),

12. 10736972 - Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis (2020-08-11),

13. 10548998 - Multimodal silica-based nanoparticles (2020-02-04),

14. 10548997 - Fluorescent silica-based nanoparticles (2020-02-04),

15. 10548989 - Nanoparticle immunoconjugates (2020-02-04),

Title: The Innovative Journey of Michelle S Bradbury

Introduction: Michelle S Bradbury is a pioneering inventor based in New York, NY, known for her groundbreaking contributions to the field of technology and healthcare.

Latest Patents: Michelle S Bradbury holds several patents in the areas of medical devices, nanotechnology, and biotechnology, showcasing her versatility and ingenuity in creating solutions for complex challenges.

Career Highlights: With a career spanning over two decades, Michelle S Bradbury has worked tirelessly to develop cutting-edge technologies that have revolutionized the industry. Her commitment to innovation and excellence has earned her recognition as a leading figure in the field.

Collaborations: Throughout her career, Michelle S Bradbury has collaborated with top research institutions, universities, and companies to bring her inventions to life. Her ability to work across disciplines and forge meaningful partnerships has been instrumental in her success.

Conclusion: Michelle S Bradbury's passion for innovation, coupled with her dedication to improving lives through technology, continues to inspire the next generation of inventors. Her impact on the industry is profound, and her legacy will undoubtedly endure for years to come.

This text is generated by artificial intelligence and may not be accurate.